AI in Trials Tilda Research offers AI Teammates that dramatically accelerate clinical trial operations, delivering faster study completion with high accuracy. This positions them to address CROs, biotech sponsors, and hospitals seeking to de-risk timelines and reduce operational bottlenecks.

Cost Reduction With claims of an 80% cost reduction and 6 months of work completed in 8 weeks, target customers include trial sponsors and contract research organizations looking to optimize budgets and improve ROI on clinical programs.

Scale and Speed The combination of rapid throughput and precision suggests opportunities with mid to large biotech firms and trial networks that run multiple concurrent studies and need scalable AI-assisted workflows.

Tech Stack Fit Leveraging cloud infrastructure (Azure), identity security (Auth0), and automation tooling (Terraform, Calendly) indicates a fit for enterprises prioritizing secure, automated, and easily integrated trial operations platforms.

Growth Signals Revenue in the narrow/mid single-digit millions and 51-200 employees imply room for expansion via enterprise deals, strategic partnerships, and expanding the sales footprint into adjacent market segments like biopharma services and digital health trial platforms.